For procurement professionals in the pharmaceutical sector, understanding the market dynamics, including price and availability, of key intermediates is crucial. Tert-Butyl (4S)-1-methyl-2-oxoimidazolidine-4-carboxylate (CAS 83056-79-5), a vital intermediate for Imidapril synthesis, is no exception. Sourcing this chemical from China offers significant advantages in terms of cost-effectiveness and supply chain resilience.

The price of Tert-Butyl (4S)-1-methyl-2-oxoimidazolidine-4-carboxylate can fluctuate based on factors such as raw material costs, production volumes, purity specifications, and supplier market positioning. As a direct manufacturer in China, we are able to offer competitive pricing for this high-purity white powder intermediate. Prospective buyers are encouraged to request detailed quotes to assess current market rates and explore potential bulk purchase discounts.

Availability is generally robust from established Chinese suppliers, especially for standard specifications like purity levels of ≥98.0%. Manufacturers often maintain inventory for research and development quantities and have well-defined processes for scaling up production to meet commercial demands. Lead times can vary depending on the order volume and the supplier's production schedule, making it important to communicate your project timelines clearly when inquiring about availability.

When planning your procurement strategy for CAS 83056-79-5, comparing offers from multiple Chinese manufacturers can help ensure you secure the best price and terms. Building a relationship with a supplier that prioritizes consistent quality and timely delivery will be instrumental in the successful synthesis of Imidapril. Don't hesitate to engage with us to discuss your specific requirements for Tert-Butyl (4S)-1-methyl-2-oxoimidazolidine-4-carboxylate and to secure a reliable, cost-effective supply.